Boulder, CO, United States of America

Soren Mogelsvang

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 10(Granted Patents)


Location History:

  • Herndon, VA (US) (2015 - 2018)
  • Boulder, CO (US) (2019 - 2021)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Soren Mogelsvang: Pioneering Peptide Research

Introduction

Soren Mogelsvang is a prominent inventor based in Boulder, Colorado, recognized for his significant contributions to peptide research. With an impressive portfolio of five patents, he has made notable strides in the treatment of various medical conditions, focusing on autoimmune, inflammatory, and metabolic diseases.

Latest Patents

Mogelsvang's latest patents include "Serpin peptides and methods of using the same," as well as "Peptides and methods of using the same." These patents detail innovative peptide formulations and their applications in treating complex diseases. His research aims to provide novel therapeutic options and improve patient outcomes in diverse medical conditions.

Career Highlights

Throughout his career, Soren has demonstrated a commitment to advancing the field of biotechnology. His work at Serpin Pharma LLC, a company dedicated to clinical advancements and peptide research, highlights his focus on practical applications of his inventions. His extensive research efforts underscore his role as a leader in the scientific community.

Collaborations

Soren collaborates closely with Cohava Gelber, sharing insights and expertise to further their research objectives. This partnership exemplifies the collaborative nature of innovation, where knowledge exchange leads to new discoveries and breakthroughs in the field.

Conclusion

Soren Mogelsvang stands out as an innovative inventor whose work with peptide technologies is paving the way for advancements in medical treatments. His dedication to research and collaboration continues to influence the biotechnology landscape, making significant contributions to the understanding and treatment of diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…